BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4092031)

  • 1. Equilibrium denaturation of pituitary- and recombinant-derived bovine growth hormone.
    Brems DN; Plaisted SM; Havel HA; Kauffman EW; Stodola JD; Eaton LC; White RD
    Biochemistry; 1985 Dec; 24(26):7662-8. PubMed ID: 4092031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of bovine growth hormone folding are consistent with a framework model.
    Brems DN; Plaisted SM; Dougherty JJ; Holzman TF
    J Biol Chem; 1987 Feb; 262(6):2590-6. PubMed ID: 3818610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium denaturation of recombinant porcine growth hormone.
    Bastiras S; Wallace JC
    Biochemistry; 1992 Sep; 31(38):9304-9. PubMed ID: 1390716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrium denaturation of buffalo pituitary growth hormone.
    Maithal K; Krishnamurty HG; Muralidhar K
    Indian J Biochem Biophys; 2001 Dec; 38(6):368-74. PubMed ID: 11989666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equilibrium denaturation of human growth hormone and its cysteine-modified forms.
    Brems DN; Brown PL; Becker GW
    J Biol Chem; 1990 Apr; 265(10):5504-11. PubMed ID: 2180927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis to probe protein folding: evidence that the formation and aggregation of a bovine growth hormone folding intermediate are dissociable processes.
    Lehrman SR; Tuls JL; Havel HA; Haskell RJ; Putnam SD; Tomich CS
    Biochemistry; 1991 Jun; 30(23):5777-84. PubMed ID: 2043617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a self-associating equilibrium intermediate during folding of human growth hormone.
    DeFelippis MR; Alter LA; Pekar AH; Havel HA; Brems DN
    Biochemistry; 1993 Feb; 32(6):1555-62. PubMed ID: 8431435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible self-association of bovine growth hormone during equilibrium unfolding.
    Havel HA; Kauffman EW; Plaisted SM; Brems DN
    Biochemistry; 1986 Oct; 25(21):6533-8. PubMed ID: 3790540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the growth-promoting, lipolytic, diabetogenic and immunological properties of pituitary and recombinant-DNA-derived bovine growth hormone (somatotropin).
    Hart IC; Chadwick PM; Boone TC; Langley KE; Rudman C; Souza LM
    Biochem J; 1984 Nov; 224(1):93-100. PubMed ID: 6391475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the galactopoietic response to pituitary-derived and recombinant-derived variants of bovine growth hormone.
    Eppard PJ; Bentle LA; Violand BN; Ganguli S; Hintz RL; Kung L; Krivi GG; Lanza GM
    J Endocrinol; 1992 Jan; 132(1):47-56. PubMed ID: 1737958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium intermediates in the denaturation of human insulin and two monomeric insulin analogs.
    Millican RL; Brems DN
    Biochemistry; 1994 Feb; 33(5):1116-24. PubMed ID: 8110743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant-DNA-derived bovine growth hormone from Escherichia coli. 1. Demonstration that the hormone is expressed in reduced form, and isolation of the hormone in oxidized, native form.
    Langley KE; Berg TF; Strickland TW; Fenton DM; Boone TC; Wypych J
    Eur J Biochem; 1987 Mar; 163(2):313-21. PubMed ID: 3545831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding of bovine growth hormone is consistent with the molten globule hypothesis.
    Brems DN; Havel HA
    Proteins; 1989; 5(1):93-5. PubMed ID: 2664767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant-DNA-derived bovine growth hormone from Escherichia coli. 2. Biochemical, biophysical, immunological and biological comparison with the pituitary hormone.
    Langley KE; Lai PH; Wypych J; Everett RR; Berg TF; Krabill LF; Davis JM; Souza LM
    Eur J Biochem; 1987 Mar; 163(2):323-30. PubMed ID: 3816808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers.
    Lai Z; McCulloch J; Lashuel HA; Kelly JW
    Biochemistry; 1997 Aug; 36(33):10230-9. PubMed ID: 9254621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression in Escherichia coli of biologically active bovine growth hormone.
    George HJ; L'Italien JJ; Pilacinski WP; Glassman DL; Krzyzek RA
    DNA; 1985 Aug; 4(4):273-81. PubMed ID: 3899556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and physiochemical properties of a recombinant bovine growth hormone produced by cultured murine fibroblasts.
    Leung FC; Jones B; Steelman SL; Rosenblum CI; Kopchick JJ
    Endocrinology; 1986 Oct; 119(4):1489-96. PubMed ID: 3757900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediates in denaturation of a small globular protein, recombinant human stefin B.
    Zerovnik E; Jerala R; Kroon-Zitko L; Pain RH; Turk V
    J Biol Chem; 1992 May; 267(13):9041-6. PubMed ID: 1577741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reoxidation of reduced bovine growth hormone from a stable secondary structure.
    Holzman TF; Brems DN; Dougherty JJ
    Biochemistry; 1986 Nov; 25(22):6907-17. PubMed ID: 3801401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of an associated folding intermediate of bovine growth hormone by site-directed mutagenesis.
    Brems DN; Plaisted SM; Havel HA; Tomich CS
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3367-71. PubMed ID: 3130626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.